John-Paul Omuojine
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
John-Paul Omuojine has a total of 103 co-authors. Here are the top co-authors by number of shared publications:
- Ruth Owusu-Antwi
Komfo Anokye Teaching Hospital, Kumasi, Ghana
3 shared publications - Cyprian Mcwayizeni Mostert
Global Brain Health Institute, Trinity College Dublin, University of Dublin, Ireland
2 shared publications - Fred Stephen Sarfo
Department of Medicine, Komfo Anokye Teaching Hospital, Kumasi 00233, Ghana
2 shared publications George Sedinam Amponsah
Komfo Anokye Teaching Hospital
2 shared publications- Kwabena Kusi-Mensah
Department of Psychiatry, University of Cambridge, Clifford Allbutt Building, Cambridge Biomedical Campus, Cambridge, CB2 OAH, UK.
2 shared publications - Leah Ratner
Division of Global Health Equity, Brigham and Women’s Hospital, Boston, Massachusetts, USA
2 shared publications
Latest Publications
- 27 July 2026
- Published by Springer Nature in Nature Health
- Vol. 1 (10) , 1045-1054
Economic interventions for lifecourse brain health in Africa
- 27 July 2026
- Published by Springer Nature in Nature Health
- Vol. 1 (10) , 1045-1054
Economic interventions for lifecourse brain health in Africa
- Open Access
- 23 July 2026
- Published by European Delirium Association in Delirium
New-onset cognitive impairment after delirium among hospitalised older Ghanaians: A Pilot Study
Background: Delirium is a potentially modifiable risk factor for dementia. However, post-delirium cognition has hardly been studied in Africa, where the burden of both disorders is rising disproportionately. Objective: We estimated the incidence of new-onset cognitive impairment (NCI) 6 months after hospitalisation with non-stroke delirium among older Ghanaians. Methods: This was a prospective observational pilot study conducted among 60 previously cognitively unimpaired (retrospective proxy assessment) adults aged ≥60 years, hospitalised with non-stroke prevalent delirium in a Tertiary Hospital. Delirium was confirmed and rated using the Confusion Assessment Method (CAM) and Severity Scale (CAM-S) within 24–72 hours of admission and reassessed twice weekly during hospitalisation, and at 6-week, 3- and 6-month follow-up visits. NCI was defined as Identification and Interventions for Dementia in Elderly Africans Study Cognitive Test (IDEA) score <8/15 + CAM-negative at 6 months. Demographic, clinical and psychosocial data were collected at baseline. We calculated the cumulative incidence function for NCI, accounting for competing mortality risk and right censoring due to dropout. We analysed predictors of NCI using Fisher’s exact test and Firth regression, and mortality using Cox proportional hazards regression. Results: The cumulative incidence of NCI was 22.4% (95% CI: 8.0–36.8%). Mortality was 42.3% (95% CI: 26.2–58.3%). NCI was associated with advanced age (≥80 years; p=.001). Mortality was associated with CAM-S at enrolment (HR: 1.153; 95% CI: 1.020–1.303), mean CAM-S during hospitalisation (HR: 1.423; 95% CI: 1.261–1.605), hyperactive delirium (HR: 2.632; 95% CI: 1.119–6.188) and frailty at 6 weeks (HR: 1.817; 95% CI: 1.001–3.297). Conclusion: In this pilot cohort of older Ghanaians hospitalized with delirium, NCI and mortality were common by 6 months. Longitudinal studies of post-delirium cognitive outcomes in diverse African cohorts are feasible and necessary, but future research should incorporate design, sampling and analytical measures to address survivor bias.
- 23 July 2026
- Published by European Delirium Association in Delirium
Open AccessNew-onset cognitive impairment after delirium among hospitalised older Ghanaians: A Pilot Study
Background: Delirium is a potentially modifiable risk factor for dementia. However, post-delirium cognition has hardly been studied in Africa, where the burden of both disorders is rising disproportionately. Objective: We estimated the incidence of new-onset cognitive impairment (NCI) 6 months after hospitalisation with non-stroke delirium among older Ghanaians. Methods: This was a prospective observational pilot study conducted among 60 previously cognitively unimpaired (retrospective proxy assessment) adults aged ≥60 years, hospitalised with non-stroke prevalent delirium in a Tertiary Hospital. Delirium was confirmed and rated using the Confusion Assessment Method (CAM) and Severity Scale (CAM-S) within 24–72 hours of admission and reassessed twice weekly during hospitalisation, and at 6-week, 3- and 6-month follow-up visits. NCI was defined as Identification and Interventions for Dementia in Elderly Africans Study Cognitive Test (IDEA) score <8/15 + CAM-negative at 6 months. Demographic, clinical and psychosocial data were collected at baseline. We calculated the cumulative incidence function for NCI, accounting for competing mortality risk and right censoring due to dropout. We analysed predictors of NCI using Fisher’s exact test and Firth regression, and mortality using Cox proportional hazards regression. Results: The cumulative incidence of NCI was 22.4% (95% CI: 8.0–36.8%). Mortality was 42.3% (95% CI: 26.2–58.3%). NCI was associated with advanced age (≥80 years; p=.001). Mortality was associated with CAM-S at enrolment (HR: 1.153; 95% CI: 1.020–1.303), mean CAM-S during hospitalisation (HR: 1.423; 95% CI: 1.261–1.605), hyperactive delirium (HR: 2.632; 95% CI: 1.119–6.188) and frailty at 6 weeks (HR: 1.817; 95% CI: 1.001–3.297). Conclusion: In this pilot cohort of older Ghanaians hospitalized with delirium, NCI and mortality were common by 6 months. Longitudinal studies of post-delirium cognitive outcomes in diverse African cohorts are feasible and necessary, but future research should incorporate design, sampling and analytical measures to address survivor bias.
- Open Access
- 30 January 2026
- Published by Springer Nature in Psychiatric Quarterly
A Survey of Health Workers in Ghana and Nigeria on the Potential Burden and Local Assessment of Executive Dysfunction Among Children
Early identification of executive dysfunction in children by non-specialist through task-shifting is imperative to attaining universal health coverage in sub-Saharan Africa. We assessed the potential burden of executive dysfunction seen by local health workers, and the potential for integrating them into assessment for cognitive functioning of children within the local healthcare system. This study was a cross-sectional in-person and online survey of 133 health workers in rural and urban Ghana and Nigeria from primary, secondary and tertiary tiers of the healthcare system. Adolescents (11 – 18 years) were the most seen age-category in primary and secondary care and by non-specialists, while school-age children (6 – 9 years) and pre-schoolers (1 – 5 years) were most seen by specialists. In decreasing order of frequency, the reported conditions likely to be associated with executive dysfunction and the cadres of workers who saw them were epilepsy and seizure-related (all workers), brain injury and neurodevelopmental delay-related complaints (secondary care workers), Attention Deficit Hyperactivity Disorder related complaints (specialists in referral centres), anxiety-related complaints (specialists in primary care) and school difficulties-related complaints (secondary care workers and non-specialists). Adolescents with Attention Deficit Hyperactivity Disorder may be going unrecognised. The Wechsler Intelligence Scale for Children/Wechsler Preschool and Primary Scale of Intelligence and the Kaufman Assessment Battery for Children (not ecologically validated) and clinical history with Mental State Exam were the most common means of assessing cognitive functioning. Potential burden of executive dysfunction among children in Ghana and Nigeria is high, and involvement of non-specialist health workers in cognitive functioning assessment is needed.
- 30 January 2026
- Published by Springer Nature in Psychiatric Quarterly
Open AccessA Survey of Health Workers in Ghana and Nigeria on the Potential Burden and Local Assessment of Executive Dysfunction Among Children
Early identification of executive dysfunction in children by non-specialist through task-shifting is imperative to attaining universal health coverage in sub-Saharan Africa. We assessed the potential burden of executive dysfunction seen by local health workers, and the potential for integrating them into assessment for cognitive functioning of children within the local healthcare system. This study was a cross-sectional in-person and online survey of 133 health workers in rural and urban Ghana and Nigeria from primary, secondary and tertiary tiers of the healthcare system. Adolescents (11 – 18 years) were the most seen age-category in primary and secondary care and by non-specialists, while school-age children (6 – 9 years) and pre-schoolers (1 – 5 years) were most seen by specialists. In decreasing order of frequency, the reported conditions likely to be associated with executive dysfunction and the cadres of workers who saw them were epilepsy and seizure-related (all workers), brain injury and neurodevelopmental delay-related complaints (secondary care workers), Attention Deficit Hyperactivity Disorder related complaints (specialists in referral centres), anxiety-related complaints (specialists in primary care) and school difficulties-related complaints (secondary care workers and non-specialists). Adolescents with Attention Deficit Hyperactivity Disorder may be going unrecognised. The Wechsler Intelligence Scale for Children/Wechsler Preschool and Primary Scale of Intelligence and the Kaufman Assessment Battery for Children (not ecologically validated) and clinical history with Mental State Exam were the most common means of assessing cognitive functioning. Potential burden of executive dysfunction among children in Ghana and Nigeria is high, and involvement of non-specialist health workers in cognitive functioning assessment is needed.
- Open Access
- 7 April 2025
- Published by Springer Nature in Social Psychiatry and Psychiatric Epidemiology
- Vol. 60 (9) , 2089-2097
Factors influencing the length of stay in the psychiatric unit of a Ghanaian teaching hospital: a retrospective study
Purpose: The psychiatric length of stay (LOS) in community-based hospital facilities in sub-Saharan Africa reflects the quality of service delivery and the presence of resource challenges. This study aimed to determine the average LOS and identify factors associated with prolonged LOS in the psychiatric unit of a Ghanaian teaching hospital. Methods: The study analysed 1143 hospital discharge records of psychiatric inpatients at Komfo Anokye Teaching Hospital Psychiatric Unit from January 2016 to October 2020. LOS greater than the median of 10 days was classified as prolonged. We performed multivariable logistic regression to determine factors associated with prolonged LOS. Results: The mean LOS was 12 days, and the median LOS was 10 days. Bipolar and related disorders (aOR = 1.68 95% CI (1.28–2.21)), substance use disorders (aOR = 1.98 95% CI (1.19–3.30)), co-occurring mental health and substance use disorders (aOR = 2.30 95% CI (1.20–4.56)), and being discharged home directly (aOR = 1.91 95% CI (1.03–3.69)) was associated with a longer hospital stay, while suicide-related behaviour (aOR = 0.27 95% CI (0.09–0.72)) was associated with decreased odds of prolonged hospital stay. Conclusion: Possible interventions to reduce the length of psychiatric stay in the general hospital setting include improving functional integration of mental health into primary care and implementing transitional treatment programmes like partial hospitalisation and intensive outpatient treatment programmes. Improving access to residential substance use treatment is another intervention that can help decrease the burden of prolonged psychiatric stays.
- 7 April 2025
- Published by Springer Nature in Social Psychiatry and Psychiatric Epidemiology
- Vol. 60 (9) , 2089-2097
Open AccessFactors influencing the length of stay in the psychiatric unit of a Ghanaian teaching hospital: a retrospective study
Purpose: The psychiatric length of stay (LOS) in community-based hospital facilities in sub-Saharan Africa reflects the quality of service delivery and the presence of resource challenges. This study aimed to determine the average LOS and identify factors associated with prolonged LOS in the psychiatric unit of a Ghanaian teaching hospital. Methods: The study analysed 1143 hospital discharge records of psychiatric inpatients at Komfo Anokye Teaching Hospital Psychiatric Unit from January 2016 to October 2020. LOS greater than the median of 10 days was classified as prolonged. We performed multivariable logistic regression to determine factors associated with prolonged LOS. Results: The mean LOS was 12 days, and the median LOS was 10 days. Bipolar and related disorders (aOR = 1.68 95% CI (1.28–2.21)), substance use disorders (aOR = 1.98 95% CI (1.19–3.30)), co-occurring mental health and substance use disorders (aOR = 2.30 95% CI (1.20–4.56)), and being discharged home directly (aOR = 1.91 95% CI (1.03–3.69)) was associated with a longer hospital stay, while suicide-related behaviour (aOR = 0.27 95% CI (0.09–0.72)) was associated with decreased odds of prolonged hospital stay. Conclusion: Possible interventions to reduce the length of psychiatric stay in the general hospital setting include improving functional integration of mental health into primary care and implementing transitional treatment programmes like partial hospitalisation and intensive outpatient treatment programmes. Improving access to residential substance use treatment is another intervention that can help decrease the burden of prolonged psychiatric stays.
- 21 October 2024
- Published by National Inquiry Services Center (NISC) in African Journal of AIDS Research
- Vol. 23 (3-4) , 92-100
Understanding depression, anxiety and stress in young people living with HIV in Ghana
Ghanaians with perinatally acquired human immunodeficiency virus (HIV) infection now live into adulthood. It is known that adolescents and young adults living with HIV have a high risk of mental health comorbidity. Despite increasing global attention on HIV-mental health interactions, the field remains understudied in Ghana, with an attendant lack of national integrated care solutions. This study aimed to measure the burden and explore the context of depression, anxiety and stress symptoms among young people living with HIV receiving care at a tertiary care hospital in Ghana. This was an explanatory sequential mixed-methods study. Depression, anxiety and stress symptoms were measured using the Depression, Anxiety and Stress Scale, and their associations with quality of life (QoL), socioeconomic status, internalised stigma, disease stage and HIV-related risk-taking behaviours were explored. After preliminary quantitative data analysis, semi-structured interviews were conducted for those who screened positive for depression and/or anxiety to explore their experience with this comorbidity. This study found a low prevalence of depression and anxiety symptoms, which were associated with higher stigma scores and lower QoL. We believe this low prevalence to be attributable to the effect of several psychosocial interventional programmes, which were previously piloted with the study cohort that have gradually normalised mental health discussions. Participants also showed marked resilience and knowledge about their condition. The results of this study present an opportunity to advocate and scale up effective locally adapted and strength-based solutions to address the mental illness-HIV syndemic in Ghanaian young people living with HIV.
- 21 October 2024
- Published by National Inquiry Services Center (NISC) in African Journal of AIDS Research
- Vol. 23 (3-4) , 92-100
Understanding depression, anxiety and stress in young people living with HIV in Ghana
Ghanaians with perinatally acquired human immunodeficiency virus (HIV) infection now live into adulthood. It is known that adolescents and young adults living with HIV have a high risk of mental health comorbidity. Despite increasing global attention on HIV-mental health interactions, the field remains understudied in Ghana, with an attendant lack of national integrated care solutions. This study aimed to measure the burden and explore the context of depression, anxiety and stress symptoms among young people living with HIV receiving care at a tertiary care hospital in Ghana. This was an explanatory sequential mixed-methods study. Depression, anxiety and stress symptoms were measured using the Depression, Anxiety and Stress Scale, and their associations with quality of life (QoL), socioeconomic status, internalised stigma, disease stage and HIV-related risk-taking behaviours were explored. After preliminary quantitative data analysis, semi-structured interviews were conducted for those who screened positive for depression and/or anxiety to explore their experience with this comorbidity. This study found a low prevalence of depression and anxiety symptoms, which were associated with higher stigma scores and lower QoL. We believe this low prevalence to be attributable to the effect of several psychosocial interventional programmes, which were previously piloted with the study cohort that have gradually normalised mental health discussions. Participants also showed marked resilience and knowledge about their condition. The results of this study present an opportunity to advocate and scale up effective locally adapted and strength-based solutions to address the mental illness-HIV syndemic in Ghanaian young people living with HIV.
- 16 April 2023
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 38 (4) , e5912
Risk factors and outcomes of delirium in hospitalized older Ghanaians
Objectives: Delirium has been rarely studied in older West Africans. We sought to investigate its correlates and outcomes in hospitalized older Ghanaians.Methods: This was a one‐month prospective observational study. Delirium prevalence was assessed within 24 h of admission using the Confusion Assessment Method (CAM). Incident delirium was determined with repeat CAM assessments on post‐admission days 4, 7, 14, 21 and 28, after censoring participants with prevalent delirium. Multivariate logistic regression analyses were used to explore risk factors. Estimates of adjusted hazard ratios for mortality were derived with the discrete time version of the Cox regression model for time invariant explanatory variables.Results: Among 483 participants, 250 (51.8%, 95% CI: 47.3–56.3) had prevalent delirium while 10 of the remaining 233 (4.3%, 95% CI: 2.1–7.8) developed incident delirium. Being older than 80 years (adjusted odds ratio (OR) = 2.1, 95% CI: 1.2–3.6), having no formal education (OR = 2.2, 95% CI: 1.4–3.4), stroke (OR = 1.8, 95% CI: 1.1–3.0), infection (OR = 1.9, 95% CI: 1.2–3.0), and high Triage Early Warning Score (OR = 6.9, 95% CI: 2.5–19.0) predicted delirium. Delirium (adjusted hazard ratio (HR) = 1.8, 95% CI: 1.0–3.3) and high TEWS (HR = 4.6 (95% CI: 1.7–12.7) at baseline predicted mortality. These factors also predicted longer hospital stay.Conclusion: Over half of hospital‐treated older Ghanaians in the present study had delirium on the first day of admission. The syndrome prolonged hospitalisation and increased mortality risk. Future studies in West Africa may investigate the epidemiology of delirium in primary care and community settings.
- 16 April 2023
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 38 (4) , e5912
Risk factors and outcomes of delirium in hospitalized older Ghanaians
Objectives: Delirium has been rarely studied in older West Africans. We sought to investigate its correlates and outcomes in hospitalized older Ghanaians.Methods: This was a one‐month prospective observational study. Delirium prevalence was assessed within 24 h of admission using the Confusion Assessment Method (CAM). Incident delirium was determined with repeat CAM assessments on post‐admission days 4, 7, 14, 21 and 28, after censoring participants with prevalent delirium. Multivariate logistic regression analyses were used to explore risk factors. Estimates of adjusted hazard ratios for mortality were derived with the discrete time version of the Cox regression model for time invariant explanatory variables.Results: Among 483 participants, 250 (51.8%, 95% CI: 47.3–56.3) had prevalent delirium while 10 of the remaining 233 (4.3%, 95% CI: 2.1–7.8) developed incident delirium. Being older than 80 years (adjusted odds ratio (OR) = 2.1, 95% CI: 1.2–3.6), having no formal education (OR = 2.2, 95% CI: 1.4–3.4), stroke (OR = 1.8, 95% CI: 1.1–3.0), infection (OR = 1.9, 95% CI: 1.2–3.0), and high Triage Early Warning Score (OR = 6.9, 95% CI: 2.5–19.0) predicted delirium. Delirium (adjusted hazard ratio (HR) = 1.8, 95% CI: 1.0–3.3) and high TEWS (HR = 4.6 (95% CI: 1.7–12.7) at baseline predicted mortality. These factors also predicted longer hospital stay.Conclusion: Over half of hospital‐treated older Ghanaians in the present study had delirium on the first day of admission. The syndrome prolonged hospitalisation and increased mortality risk. Future studies in West Africa may investigate the epidemiology of delirium in primary care and community settings.
- Open Access
- 17 October 2022
- Published by Elsevier in Psychiatry Research Communications
- Vol. 2 (4)
Use of wearable devices among individuals with depression and anxiety: A population level study
- 17 October 2022
- Published by Elsevier in Psychiatry Research Communications
- Vol. 2 (4)
Open AccessUse of wearable devices among individuals with depression and anxiety: A population level study
- 27 January 2022
- Published by Taylor & Francis in AIDS Care
- Vol. 34 (12) , 1547-1554
Course and characteristics of depression over a 12-month period among Ghanaians living with HIV: the EVERLAST study
Individuals with HIV are predisposed to depression but there is limited data on its dynamics and correlates. We aimed to assess course and characteristics of depression among Ghanaian HIV patients over a 12-month period. We interrogated a longitudinal study dataset of patients at a tertiary hospital and assessed depression at month 0 and 12 using the Patient Health Questionnaire-9 (PHQ-9). Association between clinical, sociodemographic factors and changes in PHQ-9 scores were evaluated. Among 320 study participants, 171 (53.4%) and 55 (17.2%) had depression at month 0 and 12 respectively. Persistent depression was detected in 41 (24.0%) of the 171 patients with depression at month 0, whilst 135 (42.2%) of them never experienced depression. Patients' CD4 count was associated with depression at month 0 and 12 (p<0.05). Predictors of change in depression scores were urban dwelling [–1.98, 95%CI: –3.86 to –0.06, p=0.039], not knowing one's monthly income [2.10, 95%CI: 0.58 to 3.61, p=0.007], participant being single [–1.62 95%CI: –2.45 to –0.78, p<0.001] and being on antiretroviral therapy at recruitment [–1.5, 95%CI: –2.55 to –0.45, p<0.001]. There was a significant decrease in depression scores over a 12-month period and persistent depression is rife among this cohort of Ghanaians with HIV.
- 27 January 2022
- Published by Taylor & Francis in AIDS Care
- Vol. 34 (12) , 1547-1554
Course and characteristics of depression over a 12-month period among Ghanaians living with HIV: the EVERLAST study
Individuals with HIV are predisposed to depression but there is limited data on its dynamics and correlates. We aimed to assess course and characteristics of depression among Ghanaian HIV patients over a 12-month period. We interrogated a longitudinal study dataset of patients at a tertiary hospital and assessed depression at month 0 and 12 using the Patient Health Questionnaire-9 (PHQ-9). Association between clinical, sociodemographic factors and changes in PHQ-9 scores were evaluated. Among 320 study participants, 171 (53.4%) and 55 (17.2%) had depression at month 0 and 12 respectively. Persistent depression was detected in 41 (24.0%) of the 171 patients with depression at month 0, whilst 135 (42.2%) of them never experienced depression. Patients' CD4 count was associated with depression at month 0 and 12 (p<0.05). Predictors of change in depression scores were urban dwelling [–1.98, 95%CI: –3.86 to –0.06, p=0.039], not knowing one's monthly income [2.10, 95%CI: 0.58 to 3.61, p=0.007], participant being single [–1.62 95%CI: –2.45 to –0.78, p<0.001] and being on antiretroviral therapy at recruitment [–1.5, 95%CI: –2.55 to –0.45, p<0.001]. There was a significant decrease in depression scores over a 12-month period and persistent depression is rife among this cohort of Ghanaians with HIV.
- Open Access
- 23 November 2021
- Published by F1000 Research Ltd in Open Research Africa
- Vol. 4, 29
Pharmacological management of seizures in patients with COVID-19: a systematic review
Background: Some patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been reported to exhibit neurological symptoms such as seizures and impaired consciousness. Our study reviews reported cases to assess the pharmacological approach to managing seizures in SARS-CoV-2 patients and associated outcomes. Methods: A systematic review of case reports on the incidence of seizures following coronavirus disease 2019 (COVID-19) among patients that reported use of antiepileptic drugs (AEDs) in management was performed by using the PRISMA (preferred reporting items for systematic reviews and meta-analysis) guidelines. Databases used included EMBASE, PubMed, SCOPUS, and Google Scholar. Data was presented as qualitative and descriptive data. Results: In total, 67 articles were selected for full-text assessment, of which 18 were included in the final review. Patients had a median age of 54 years, most of whom were male. Remdisivir, dexamethasone, Laninamivir, hydroxychloroquine, azithromycin, and Lopinavir-ritonavir were common agents used in the management of COVID-19. Most patients presented with either generalized tonic-clonic seizures or status epilepticus. Most patients received levetiracetam as drug choice or as part of their regimen. Other AEDs commonly prescribed included midazolam and sodium valproate. Some patients received no antiepileptic drug therapy. Most of the patients who died had more than one comorbidity. Also, most of the patients who died received COVID-19 treatment drugs. None of the patients who received midazolam as drug choice or as part of their regimen developed recurrent seizures in contrast to patients who received levetiracetam and sodium valproate as drug choice or as part of their regimen. Interestingly, none of the patients who received no AEDs suffered recurrent seizures or died. Conclusions: Standard guidelines for managing seizures in COVID-19 patients may be required. A limitation of this review is that it involved the use of case reports with no controls and a small number of patients.
- 23 November 2021
- Published by F1000 Research Ltd in Open Research Africa
- Vol. 4, 29
Open AccessPharmacological management of seizures in patients with COVID-19: a systematic review
Background: Some patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been reported to exhibit neurological symptoms such as seizures and impaired consciousness. Our study reviews reported cases to assess the pharmacological approach to managing seizures in SARS-CoV-2 patients and associated outcomes. Methods: A systematic review of case reports on the incidence of seizures following coronavirus disease 2019 (COVID-19) among patients that reported use of antiepileptic drugs (AEDs) in management was performed by using the PRISMA (preferred reporting items for systematic reviews and meta-analysis) guidelines. Databases used included EMBASE, PubMed, SCOPUS, and Google Scholar. Data was presented as qualitative and descriptive data. Results: In total, 67 articles were selected for full-text assessment, of which 18 were included in the final review. Patients had a median age of 54 years, most of whom were male. Remdisivir, dexamethasone, Laninamivir, hydroxychloroquine, azithromycin, and Lopinavir-ritonavir were common agents used in the management of COVID-19. Most patients presented with either generalized tonic-clonic seizures or status epilepticus. Most patients received levetiracetam as drug choice or as part of their regimen. Other AEDs commonly prescribed included midazolam and sodium valproate. Some patients received no antiepileptic drug therapy. Most of the patients who died had more than one comorbidity. Also, most of the patients who died received COVID-19 treatment drugs. None of the patients who received midazolam as drug choice or as part of their regimen developed recurrent seizures in contrast to patients who received levetiracetam and sodium valproate as drug choice or as part of their regimen. Interestingly, none of the patients who received no AEDs suffered recurrent seizures or died. Conclusions: Standard guidelines for managing seizures in COVID-19 patients may be required. A limitation of this review is that it involved the use of case reports with no controls and a small number of patients.
- Open Access
- 9 June 2021
- Published by F1000 Research Ltd in AAS Open Research
- Vol. 4, 29
Pharmacological management of seizures in patients with COVID-19: a systematic review
Background: Some patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been reported to exhibit neurological symptoms such as seizures and impaired consciousness. Our study reviews reported cases to assess the pharmacological approach to managing seizures in SARS-CoV-2 patients and associated outcomes. Methods: A systematic review of case reports on the incidence of seizures following coronavirus disease 2019 (COVID-19) among patients that reported use of antiepileptic drugs (AEDs) in management was performed by using the PRISMA (preferred reporting items for systematic reviews and meta-analysis) guidelines. Databases used included EMBASE, PubMed, SCOPUS, and Google Scholar. Data was presented as qualitative and descriptive data. Results: In total, 67 articles were selected for full-text assessment, of which 19 were included in the final review. Patients had a median age of 54 years, most of whom were male. Remdisivir, dexamethasone, Laminavir, hydroxychloroquine, azithromycin, and Lopinavir-ritonavir were common agents used in the management of COVID-19. Most patients presented with either generalized tonic-clonic seizures or status epilepticus. Most patients received levetiracetam as drug choice or as part of their regimen. Other AEDs commonly prescribed included midazolam and sodium valproate. Some patients received no antiepileptic drug therapy. Most of the patients who died had more than one comorbidity. Also, most of the patients who died received COVID-19 treatment drugs. None of the patients who received midazolam as drug choice or as part of their regimen developed recurrent seizures in contrast to patients who received levetiracetam and sodium valproate as drug choice or as part of their regimen. Interestingly, none of the patients who received no AEDs suffered recurrent seizures or died. Conclusions: Standard guidelines for managing seizures in COVID-19 patients may be required. A limitation of this review is that it involved the use of case reports with no controls and a small number of patients.
- 9 June 2021
- Published by F1000 Research Ltd in AAS Open Research
- Vol. 4, 29
Open AccessPharmacological management of seizures in patients with COVID-19: a systematic review
Background: Some patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been reported to exhibit neurological symptoms such as seizures and impaired consciousness. Our study reviews reported cases to assess the pharmacological approach to managing seizures in SARS-CoV-2 patients and associated outcomes. Methods: A systematic review of case reports on the incidence of seizures following coronavirus disease 2019 (COVID-19) among patients that reported use of antiepileptic drugs (AEDs) in management was performed by using the PRISMA (preferred reporting items for systematic reviews and meta-analysis) guidelines. Databases used included EMBASE, PubMed, SCOPUS, and Google Scholar. Data was presented as qualitative and descriptive data. Results: In total, 67 articles were selected for full-text assessment, of which 19 were included in the final review. Patients had a median age of 54 years, most of whom were male. Remdisivir, dexamethasone, Laminavir, hydroxychloroquine, azithromycin, and Lopinavir-ritonavir were common agents used in the management of COVID-19. Most patients presented with either generalized tonic-clonic seizures or status epilepticus. Most patients received levetiracetam as drug choice or as part of their regimen. Other AEDs commonly prescribed included midazolam and sodium valproate. Some patients received no antiepileptic drug therapy. Most of the patients who died had more than one comorbidity. Also, most of the patients who died received COVID-19 treatment drugs. None of the patients who received midazolam as drug choice or as part of their regimen developed recurrent seizures in contrast to patients who received levetiracetam and sodium valproate as drug choice or as part of their regimen. Interestingly, none of the patients who received no AEDs suffered recurrent seizures or died. Conclusions: Standard guidelines for managing seizures in COVID-19 patients may be required. A limitation of this review is that it involved the use of case reports with no controls and a small number of patients.